PDCI Market Access | Events

November 22, 2022 / PDCI, What's New

PDCI is congratulating its Managing Director, Kaitlyn Proulx, as she begins parental leave effective November ... Read More

October 13, 2022 / News, PMPRB

On October 6, 2022, the Patented Medicine Prices Review Board (PMPRB) published its highly anticipated draft price regulatory ... Read More

October 6, 2022 / News, PMPRB, What's New

The Patented Medicine Prices Review Board (PMPRB) today, Ocober 6, 2022, released its draft PMPRB ... Read More

August 19, 2022 / PMPRB, What's New

On August 18, 2022, PMPRB announced its decisions regarding Price Regulation of patented medicines during the ‘Interim Period’, ... Read More

July 20, 2022 / PMPRB, What's New

On June 30, 2022, PMPRB issued a Notice and Comment which published its Proposed Interim Guidance and invited ... Read More

June 30, 2022 / News, PMPRB

PMPRB Launches Consultation on its Proposed Interim Guidance Today, June 30, 2022, PMPRB published a ... Read More

June 28, 2022 / News, What's New

François-Xavier has joined PDCI Market Access as a Senior Health Economist. He is responsible for ... Read More